# FDA recall D-0552-2026

> **Eugia US LLC** · Class III · drug recall initiated 2026-05-18.

## Product

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520.  NDC: 55150-164-02

## Reason for recall

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

## Distribution

US Nationwide.

## Key facts

- **Recall number:** D-0552-2026
- **Recalling firm:** Eugia US LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-05-18
- **Report date:** 2026-06-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Windsor, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0552-2026

## Citation

> MORVS. FDA recall D-0552-2026. Retrieved 2026-10-12 from https://api.morvs.ai/recall/D-0552-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*